gastric cancer

Showing NaN - NaN of 88

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gastric Cancer Trial in Shanghai (NK510, Tislelizumab,atezolizumab or Trastuzumab)

Enrolling by invitation
  • Gastric Cancer
  • NK510
  • Tislelizumab,atezolizumab or Trastuzumab
  • Shanghai, China
    Shanghai Tenth People's Hospital
Oct 22, 2023

Gastric Cancer, HER2-low-expressing Gastric Cancer Trial in Shanghai (Disitamab Vedotin, Toripalimab)

Recruiting
  • Gastric Cancer
  • HER2-low-expressing Gastric Cancer
  • Shanghai, China
    Shanghai East Hospital
Oct 9, 2023

Gastric Cancer Trial in Shanghai (sintilimab+metronomic PLOF)

Recruiting
  • Gastric Cancer
  • sintilimab+metronomic PLOF
  • Shanghai, China
    Huashan Hospital, Fudan University
Sep 22, 2023

Gastric Cancer Response to Neoadjuvant Chemotherapy

Not yet recruiting
  • Gastric Cancer
  • +2 more
  • Neoadjuvant Chemotherapy
  • Beijing, China
  • +21 more
Sep 6, 2023

Gastric Cancer, Chemo Effect, Immune Checkpoint Inhibitor Trial in Shanghai (Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU)

Recruiting
  • Gastric Cancer
  • +2 more
  • Sintilimab, paclitaxel-albumin, oxaliplatin, 5-FU
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 1, 2023

Gastric Cancer Trial in Shanghai (Serplulimab, Trastuzuma, Chemotherapy)

Recruiting
  • Gastric Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 27, 2023

Gastric Cancer Trial in China (Experimental dose: modified XELOX + sintilimab, Standard dose: standard XELOX + sintilimab)

Recruiting
  • Gastric Cancer
  • Experimental dose: modified XELOX + sintilimab
  • Standard dose: standard XELOX + sintilimab
  • Guangzhou, Guangdong, China
  • +9 more
Jun 23, 2023

Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))

Recruiting
  • Sarcoma
  • +8 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Shanghai, Jiangsu, China
    Xuzhou Second People's Hospital
May 8, 2023

Advanced Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Guangzhou, Zhengzhou, Chengdu (CMG901)

Recruiting
  • Advanced Solid Tumor
  • +3 more
  • Guangzhou, Guangdong, China
  • +31 more
Dec 26, 2022

Gastric Cancer Trial in Worldwide (Bemarituzumab, Placebo, Modified FOLFOX6)

Completed
  • Gastric Cancer
  • Bemarituzumab
  • +2 more
  • Tucson, Arizona
  • +188 more
Dec 15, 2022

Gastric Cancer Trial in Shanghai (68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT)

Recruiting
  • Gastric Cancer
  • 68Ga-FAPI-04 PET/CT and 18F-FDG PET/CT
  • Shanghai, Shanghai, China
    Shanghai Ruijin Hospital
Dec 2, 2022

Gastric Cancer Trial in China (IN10018, Docetaxel)

Completed
  • Gastric Cancer
  • Anyang, Henan, China
  • +7 more
Nov 15, 2022

Gastric Cancer, Small-cell Lung Cancer Trial in China, Korea, Republic of, Taiwan (EP0057, Olaparib tablets)

Not yet recruiting
  • Gastric Cancer
  • Small-cell Lung Cancer
  • Shanghai, Changning District, 交通大学 邮政编码, China
  • +20 more
Nov 1, 2022

Hypoxia, Gastric Cancer, Sedation Complication Trial in Shanghai, Jiaxing, Nanchang (Remimazolam tosylate, Propofol)

Recruiting
  • Hypoxia
  • +3 more
  • Shanghai, Shanghai, China, China
  • +4 more
Oct 7, 2022

Gastric Cancer Trial in Shanghai (laparoscopy-assisted distal gastrectomy Group, Totally laparoscopic distal gastrectomy)

Recruiting
  • Gastric Cancer
  • laparoscopy-assisted distal gastrectomy Group
  • Totally laparoscopic distal gastrectomy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 12, 2022

Gastric Cancer Trial in Shanghai (Total Gastrectomy)

Recruiting
  • Gastric Cancer
  • Total Gastrectomy
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Sep 8, 2022

Gastric Cancer Trial in Shanghai (PLD, Oxaliplatin, Capecitabine)

Recruiting
  • Gastric Cancer
  • Shanghai, China
    Shanghai General Hospital
Sep 7, 2022

Hypoxia, Gastric Cancer, Gastric Polyp Trial in Zhengzhou, Shanghai, Kunming (nasal mask oxygen kit, regular nasal cannula)

Recruiting
  • Hypoxia
  • +5 more
  • nasal mask oxygen kit
  • regular nasal cannula
  • Zhengzhou, Henan, China
  • +2 more
Sep 6, 2022

Gastric Cancer, Gastroesophageal Junction Cancer, HER2-positive Gastric Cancer Trial in Worldwide (margetuximab, Retifanlimab,

Active, not recruiting
  • Gastric Cancer
  • +2 more
  • margetuximab
  • +4 more
  • Scottsdale, Arizona
  • +72 more
Aug 24, 2022

Gastric Cancer, Gastroesophageal Junction Cancer Trial in China (Pembrolizumab, Placebo, Cisplatin)

Recruiting
  • Gastric Cancer
  • Gastroesophageal Junction Cancer
  • Pembrolizumab
  • +7 more
  • Beijing, Beijing, China
  • +12 more
Aug 17, 2022

Gastric Cancer Trial in Shanghai (camrelizumab+chemo, Chemotherapy)

Recruiting
  • Gastric Cancer
  • Shanghai, Shanghai, China
    Ruijin Hospital
Aug 9, 2022

Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in China, United States (TJ033721)

Recruiting
  • Solid Tumor
  • +6 more
  • Orange, California
  • +17 more
Aug 9, 2022

MSI-H, PD-1 Immunotherapy, Gastric Cancer Trial in Shanghai (SOX, XELOX, Observation)

Not yet recruiting
  • MSI-H
  • +3 more
  • Shanghai, China
    Dazhi Xu
Jul 20, 2022

Ovarian Cancer, Breast Cancer, Pancreatic Cancer Trial in Worldwide (AZD5305, Paclitaxel, Carboplatin)

Recruiting
  • Ovarian Cancer
  • +12 more
  • San Francisco, California
  • +44 more
Jul 12, 2022